You are here
Mega deals morph into mega problems for Wall Street
IF 2015 was a dream year for Wall Street's top dealmakers, 2016 is starting to take a nightmarish turn.
Some of the mega transactions that had champagne corks popping in boardrooms are running into antitrust problems and, in the case of pharmaceutical firm Pfizer's US$160
- CALL +65 6388 3838
- EMAIL email@example.com